ReviewFrontiers in aging neuroscience2025

The potential and challenges of TREM2-targeted therapy in Alzheimer's disease: insights from the INVOKE-2 study.

Ya-Nan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.